{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:25:20Z","timestamp":1775665520376,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,8]]},"DOI":"10.7759\/cureus.106657","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T15:40:53Z","timestamp":1775662853000},"source":"Crossref","is-referenced-by-count":0,"title":["Acute Stroke Patients on Daily Anticoagulant or Antiplatelet Therapy Receiving Thrombolysis or Thrombectomy"],"prefix":"10.7759","author":[{"given":"Scott M","family":"Alter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salil","family":"Phadnis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuheir","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua J","family":"Solano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick G","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart Disease and Stroke Statistics: 2020 update: a report from the American Heart Association","volume":"141","author":"Virani SS","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ, et al.. Heart Disease and Stroke Statistics: 2020 update: a report from the American Heart Association. Circulation. 2020, 141:e139-596. 10.1161\/CIR.0000000000000757","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","year":"1995","unstructured":"Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995, 333.1581-8. 10.1056\/NEJM199512143332401","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"Hacke W","year":"2008","unstructured":"Hacke W, Kaste M, Bluhmki E, et al.. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008, 359:1317-29. 10.1056\/NEJMoa0804656","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000513","article-title":"2026 guideline for the early management of patients with acute ischemic stroke: a guideline from the American Heart Association\/American Stroke Association","author":"Prabhakaran S","year":"2026","unstructured":"Prabhakaran S, Gonzalez NR, Zachrison KS, et al.. 2026 guideline for the early management of patients with acute ischemic stroke: a guideline from the American Heart Association\/American Stroke Association. Stroke. 2026, 10.1161\/STR.0000000000000513","journal-title":"Stroke"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000086","article-title":"Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"47","author":"Demaerschalk BM","year":"2016","unstructured":"Demaerschalk BM, Kleindorfer DO, Adeoye OM, et al.. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2016, 47:581-641. 10.1161\/STR.0000000000000086","journal-title":"Stroke"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.703258","article-title":"Hemorrhagic transformation after ischemic stroke: mechanisms and management","volume":"12","author":"Hong JM","year":"2021","unstructured":"Hong JM, Kim DS, Kim M. Hemorrhagic transformation after ischemic stroke: mechanisms and management. Front Neurol. 2021, 12:703258. 10.3389\/fneur.2021.703258","journal-title":"Front Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.54.12.1044","article-title":"The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results","volume":"54","author":"Farrell B","year":"1991","unstructured":"Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry. 1991, 54:1044-54. 10.1136\/jnnp.54.12.1044","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/SVIN.121.000366","article-title":"Asymptomatic intracranial hemorrhage is associated with poor outcomes after mechanical thrombectomy for large vessel occlusion","volume":"2","author":"Suzuki K","year":"2022","unstructured":"Suzuki K, Matsumaru Y, Takeuchi M, et al.. Asymptomatic intracranial hemorrhage is associated with poor outcomes after mechanical thrombectomy for large vessel occlusion. Stroke Vasc Interv Neurol. 2022, 2:e000366. 10.1161\/SVIN.121.000366","journal-title":"Stroke Vasc Interv Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/0972-2327.165480","article-title":"Stroke rehabilitation: which factors influence the outcome?","volume":"18","author":"Du\u0161ica SP","year":"2015","unstructured":"Du\u0161ica SP, Deve\u010derski GV, Jovi\u0107evi\u0107 MN, Plati\u0161a NM. Stroke rehabilitation: which factors influence the outcome?. Ann Indian Acad Neurol. 2015, 18:484-7. 10.4103\/0972-2327.165480","journal-title":"Ann Indian Acad Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.0948","article-title":"Association of recent use of non-vitamin K antagonist oral anticoagulants with intracranial hemorrhage among patients with acute ischemic stroke treated with alteplase","volume":"327","author":"Kam W","year":"2022","unstructured":"Kam W, Holmes DN, Hernandez AF, et al.. Association of recent use of non-vitamin K antagonist oral anticoagulants with intracranial hemorrhage among patients with acute ischemic stroke treated with alteplase. JAMA. 2022, 327:760-71. 10.1001\/jama.2022.0948","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2022.4782","article-title":"Intravenous thrombolysis in patients with ischemic stroke and recent ingestion of direct oral anticoagulants","volume":"80","author":"Meinel TR","year":"2023","unstructured":"Meinel TR, Wilson D, Gensicke H, et al.. Intravenous thrombolysis in patients with ischemic stroke and recent ingestion of direct oral anticoagulants. JAMA Neurol. 2023, 80:233-43. 10.1001\/jamaneurol.2022.4782","journal-title":"JAMA Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2023.05.084","article-title":"Safety of mechanical thrombectomy in patients on antiplatelet\/anticoagulation","volume":"176","author":"Amllay A","year":"2023","unstructured":"Amllay A, Becerril-Gaitan A, Hunt A, et al.. Safety of mechanical thrombectomy in patients on antiplatelet\/anticoagulation. World Neurosurg. 2023, 176:e476-84. 10.1016\/j.wneu.2023.05.084","journal-title":"World Neurosurg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-018-1902-7","article-title":"Mechanical thrombectomy in patients with acute ischemic stroke on anticoagulation therapy","volume":"41","author":"\u010cern\u00edk D","year":"2018","unstructured":"\u010cern\u00edk D, \u0160a\u0148\u00e1k D, Divi\u0161ov\u00e1 P, et al.. Mechanical thrombectomy in patients with acute ischemic stroke on anticoagulation therapy. Cardiovasc Intervent Radiol. 2018, 41:706-11. 10.1007\/s00270-018-1902-7","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11926-5","article-title":"Outcomes of mechanical thrombectomy in orally anticoagulated patients with anterior circulation large vessel occlusion: a propensity-matched analysis of the Imperial College Thrombectomy Registry","volume":"270","author":"D'Anna L","year":"2023","unstructured":"D'Anna L, Romoli M, Foschi M, et al.. Outcomes of mechanical thrombectomy in orally anticoagulated patients with anterior circulation large vessel occlusion: a propensity-matched analysis of the Imperial College Thrombectomy Registry. J Neurol. 2023, 270:5827-34. 10.1007\/s00415-023-11926-5","journal-title":"J Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.12.027","article-title":"Safety of endovascular intervention for stroke on therapeutic anticoagulation: multicenter cohort study and meta-analysis","volume":"26","author":"Kurowski D","year":"2017","unstructured":"Kurowski D, Jonczak K, Shah Q, et al.. Safety of endovascular intervention for stroke on therapeutic anticoagulation: multicenter cohort study and meta-analysis. J Stroke Cerebrovasc Dis. 2017, 26:1104-9. 10.1016\/j.jstrokecerebrovasdis.2016.12.027","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105678","article-title":"Safety of intravenous thrombolysis for acute ischemic stroke in patients taking warfarin with subtherapeutic INR","volume":"30","author":"Mowla A","year":"2021","unstructured":"Mowla A, Memon A, Razavi SM, et al.. Safety of intravenous thrombolysis for acute ischemic stroke in patients taking warfarin with subtherapeutic INR. J Stroke Cerebrovasc Dis. 2021, 30:105678. 10.1016\/j.jstrokecerebrovasdis.2021.105678","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.118.020890","article-title":"Reversal of vitamin K antagonist therapy before thrombolysis for acute ischemic stroke","volume":"49","author":"Chausson N","year":"2018","unstructured":"Chausson N, Soumah D, Aghasaryan M, Altarcha T, Alecu C, Smadja D. Reversal of vitamin K antagonist therapy before thrombolysis for acute ischemic stroke. Stroke. 2018, 49:2526-8. 10.1161\/STROKEAHA.118.020890","journal-title":"Stroke"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5853\/jos.2017.00395","article-title":"Intravenous thrombolysis in patients with stroke taking rivaroxaban using drug specific plasma levels: experience with a standard operation procedure in clinical practice","volume":"19","author":"Seiffge DJ","year":"2017","unstructured":"Seiffge DJ, Traenka C, Polymeris AA, et al.. Intravenous thrombolysis in patients with stroke taking rivaroxaban using drug specific plasma levels: experience with a standard operation procedure in clinical practice. J Stroke. 2017, 19:347-55. 10.5853\/jos.2017.00395","journal-title":"J Stroke"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/437452-acute-stroke-patients-on-daily-anticoagulant-or-antiplatelet-therapy-receiving-thrombolysis-or-thrombectomy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T15:40:53Z","timestamp":1775662853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/437452-acute-stroke-patients-on-daily-anticoagulant-or-antiplatelet-therapy-receiving-thrombolysis-or-thrombectomy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.106657","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,8]]}}}